Clinical protocol. Intra-Lesional rF-B7.1 versus rF-TRICOM vaccine in the treatment of metastatic cancer.
Kaufman
Howard L
HL
Department of Surgery, Columbia Presbyterian Medical Center, New York, NY 10032, USA. hlk2003@columbia.edu
Cheung
Kenneth
K
Haskall
Ziv
Z
Horig
Heidi
H
Hesdorffer
Charles
C
Panicali
Dennis
D
DeRaffele
Gail
G
Spanknebel
Kathryn
K
D000328:Adult; D019496:Cancer Vaccines / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D002985:Clinical Protocols; D032962:Consent Forms; D004339:Drug Compounding; D006801:Humans; D015552:Injections, Intralesional; D009362:Neoplasm Metastasis / Q000276:immunology / Q000628:therapy*; D018579:Patient Selection; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000235:genetics / Q000627:therapeutic use*
D019496:Cancer Vaccines; D014614:Vaccines, Synthetic; C479601:rF-B7.1 vaccine; C479602:rF-TRICOM vaccine